Literature DB >> 6337962

Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.

W Kiowski, O Bertel, P Erne, P Bolli, U L Hulthén, R Ritz, F R Bühler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6337962     DOI： 10.1161/01.hyp.5.2_pt_2.i70

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

Review 1.  Medical management of primary hyperaldosteronism.

Authors:  E L Bravo
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 2.  Use of nifedipine in hypertension and Raynaud's phenomenon.

Authors:  W Kiowski; P Erne; F R Bühler
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

4.  The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension.

Authors:  S Capewell; C G Wathen; W J Hannan; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

6.  Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension. The Enalapril vs Nifedipine French Study Group.

Authors:  P Gueret; J Y Artigou; M Benichou; J Berland; P Fressinaud; G Grollier; C D Nguyen
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 7.  Treatment of severe hypertension and hypertensive crises with nifedipine.

Authors:  M C Houston
Journal:  West J Med       Date:  1987-06

8.  Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.

Authors:  F H Leenen; R J Burns; M G Myers; D Frankel
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

9.  Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.

Authors:  J Leppert; H Nilsson; U Myrdal; L Edvinsson; T Hedner; I Ringqvist
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

10.  The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.

Authors:  J Wilson; M M Wahbha; P G Martin; R Hainsworth; A M Brownjohn; J H Turney; J A Davies; C R Prentice
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.